V617F
V617F · SaudiVarKB evidence summary derived from retained literature mentions.
10Variant mentions
10Publications
9Associated gene records
5Associated phenotype records
Associated gene records
Co-mentioned in the same publicationsAssociated phenotype records
Co-mentioned in the same publications| Phenotype | Identifier / context | Articles | Mentions |
|---|---|---|---|
| leukemia | — | 3 | 3 |
| hypertension | — | 1 | 1 |
| diabetes mellitus | — | 1 | 1 |
| von Willebrand disease | — | 1 | 1 |
| stroke | — | 1 | 1 |
Associated population records
Co-mentioned in the same publications| Population | Identifier / context | Articles | Mentions |
|---|---|---|---|
| Saudi Arabia | Cohort 60 | 1 | 1 |
| Saudi Arabia | Cohort 100 | 1 | 1 |
| Saudi Arabia | Cohort 0 | 1 | 1 |
| Population record | Cohort 90 | 1 | 1 |
| Saudi Arabia · Eastern Province | Cohort 112 | 1 | 1 |
Supporting publications
10 records- 2024Prevalence of JAK 2 v617 Mutations in Malignant and Non-Malignant Tumors in the Eastern Province of the Kingdom of Saudi Arabia.Clinical laboratory1 mentions
- 2024The Association Between Janus Kinase 2 and Factor V Leiden Mutations and Thrombotic Complications in Patients With Myeloproliferative Disorders: A Study From Saudi Arabia.Cureus1 mentions
- 2023A 68-Year-Old Man with a Cytogenetic Diagnosis of Chronic Myeloid Leukemia and Bone Marrow Findings of Philadelphia Chromosome Translocation Between the Long Arm of Chromosomes 9 and 22, Leading to the BCR-ABL1 Fusion Gene and V617F Mutation in the JAK2 Gene.The American journal of case reports1 mentions
- 2023Janus Kinase-Signal Transducer and Activator of Transcription Inhibitors for the Treatment and Management of Cancer.Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer1 mentions
- 2022Screening of V617F mutation in JAK2 gene with acute myeloid leukemia in the Saudi population.Acta biochimica Polonica1 mentions
- 2022Oral squamous cell carcinoma with essential thrombocythemia and positive JAK2 (V617F) mutation.Journal of Taibah University Medical Sciences1 mentions
- 2021Essential Thrombocythemia in Children: A Retrospective Study.Journal of hematology1 mentions
- 2020Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5.Human cell1 mentions
- 2019An Update on JAK Inhibitors.Current medicinal chemistry1 mentions
- 2019JAK2 and Beyond: Mutational Study of JAK2V617 in Myeloproliferative Disorders and Haematological Malignancies in Kashmiri population.Asian Pacific journal of cancer prevention : APJCP1 mentions